These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4398277)

  • 21. Studies on the inhibition of C56 initiated lysis (reactive lysis). I. Description of the phenomenon and methods of assay.
    McLeod B; Baker P; Gewurz H
    Immunology; 1974 Jun; 26(6):1145-57. PubMed ID: 4137213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superiority of human complement for assaying bacterial lipopolysaccharides by their anticomplementary activity.
    Saddler JN; Wardlaw AC
    Experientia; 1978 Sep; 34(9):1227-8. PubMed ID: 363447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversible loss of activity of the first component of complement (C'1) as a function of ionic strength.
    Colten HR; Borsos T; Rapp HJ
    J Immunol; 1968 Apr; 100(4):799-807. PubMed ID: 5645221
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticomplementary and hypoglycemic activity of okra and hibiscus mucilages.
    Tomoda M; Shimizu N; Gonda R; Kanari M; Yamada H; Hikino H
    Carbohydr Res; 1989 Jul; 190(2):323-8. PubMed ID: 2805010
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
    Kempf RA; Gigli I; Austen KF
    J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement inhibitor(s) released by leukocytes. I. Pretreatment of sheep erythrocytes with supernatants of mouse spleen and thymus cells inhibit whole complement activity and C2 utilization.
    Bernard A; Boumsell L; Borsos T; Good RA; Day NK
    J Immunol; 1975 Oct; 115(4):1087-90. PubMed ID: 1176766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the activated Cls subunit of the first component of complement by antithrombin III in the presence of heparin.
    Ogston D; Murray J; Crawford GP
    Thromb Res; 1976 Sep; 9(3):217-222. PubMed ID: 982345
    [No Abstract]   [Full Text] [Related]  

  • 28. [Action of the heparin-protamine complex on serum complement. Research in vitro and in vivo].
    Di Perri T; Grossi A; Auteri A
    Boll Soc Ital Biol Sper; 1969 Aug; 45(16):1085-7. PubMed ID: 5374944
    [No Abstract]   [Full Text] [Related]  

  • 29. Dendritic polyglycerol sulfates as new heparin analogues and potent inhibitors of the complement system.
    Türk H; Haag R; Alban S
    Bioconjug Chem; 2004; 15(1):162-7. PubMed ID: 14733596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
    Ruddy S; Austen KF
    J Immunol; 1971 Sep; 107(3):742-50. PubMed ID: 4999095
    [No Abstract]   [Full Text] [Related]  

  • 31. Activation of the first component of complement evidence for an internal activation step.
    Loos M; Borsos T; Rapp HJ
    J Immunol; 1972 Mar; 108(3):683-8. PubMed ID: 5011751
    [No Abstract]   [Full Text] [Related]  

  • 32. [In vitro inhibitory effect of phenylbutazone on the hemolytic activity of complement in guinea pigs].
    Lang JM; Hainaut J
    Agressologie; 1972; 13(2):117-20. PubMed ID: 5078837
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacological effects on the complement system. Possibilities and limitations of anti-inflammatory therapy].
    Kirschfink M
    Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1087-90. PubMed ID: 7641591
    [No Abstract]   [Full Text] [Related]  

  • 34. [Demonstration, by the kinetic method, of the additivity of anticomplementary effects].
    Vargues R; Audurier A
    C R Seances Soc Biol Fil; 1968; 162(2):544-8. PubMed ID: 4236643
    [No Abstract]   [Full Text] [Related]  

  • 35. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    Ruddy S; Austen KF
    J Immunol; 1969 Mar; 102(3):533-43. PubMed ID: 5813010
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.
    Glovsky MM; Cory M; Alenty A
    Immunology; 1974 Apr; 26(4):819-29. PubMed ID: 4136824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on several biochemical properties of the sulfuric polyester of pentosan in relation to histamine].
    Mordelet-Dambrine M; Prevot N
    Bull Soc Chim Biol (Paris); 1970; 52(12):1351-61. PubMed ID: 4396255
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro and ex vivo regulation of vascular smooth muscle cell growth and phenotypic modulation by sulphated polysaccharides.
    Herbert JM; Nuti D; Paul R; Maffrand JP
    Artery; 1988; 16(1):1-14. PubMed ID: 2462861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anticomplement function of heparin].
    Huang SW
    Sheng Li Ke Xue Jin Zhan; 1984 Oct; 15(4):360-3. PubMed ID: 6544523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.